Medicine and Dentistry
Body Mass Index
25%
Cardiovascular System
12%
Clopidogrel
100%
Combination Therapy
12%
CYP2C19
87%
CYP2C9
25%
Follow up
25%
Genetic Polymorphism
37%
Heredity
100%
Inpatient
100%
Loading Drug Dose
62%
Maintenance Drug Dose
75%
Patient
75%
Percutaneous Coronary Intervention
37%
Platelet Reactivity
75%
Proton-Pump Inhibitor
12%
Stent
12%
Vasodilator Stimulated Phosphoprotein
12%
Biochemistry, Genetics and Molecular Biology
Allele
25%
Body Mass
25%
Clopidogrel
100%
CYP2C19
87%
CYP2C9
25%
Cytochrome
12%
Dose
100%
Genetic Determinism
100%
Genetic Polymorphism
37%
Loading Drug Dose
62%
Maintenance Drug Dose
75%
Platelet Reactivity
75%
Proton Pump
12%
Reduction (Chemistry)
12%
Vasodilator-Stimulated Phosphoprotein
12%
Nursing and Health Professions
Body Mass
25%
Clopidogrel
100%
Combination Therapy
12%
Cytochrome
12%
Cytochrome P450 2C19
87%
Cytochrome P450 2C9
25%
Dose
100%
Follow up
25%
Loading Drug Dose
62%
Maintenance Drug Dose
75%
Percutaneous Coronary Intervention
37%
Vasodilator Stimulated Phosphoprotein
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clopidogrel
100%
CYP2C19
87%
CYP2C9
25%
Cytochrome
12%
Maintenance Dose
75%
Proton Pump Inhibitor
12%
Vasodilator Stimulated Phosphoprotein
12%